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Introduction
Of all colorectal cancers, 80% to 90% are sporadic and 10% to 20% are familial.
The cause of sporadic colorectal cancer is multifactorial with environmental
factors playing a major role. First-degree relatives of patients with colorectal
cancer have an increased risk for colorectal cancer. The risk is greater if
diagnosis is made at a young age and if other first-degree relatives are affected.
Case-control studies on familial risk have not been performed in Asian countries
except Japan.1
Certain medical and colorectal diseases have been associated with colorectal
cancer due to shared lifestyle factors or genetic predisposition. Identification of
these high-risk individuals in the local population is important so that targeted
preventive measures can be devised.
Risk modification involving lifestyle changes can be difficult to implement.
Therefore, modifiers of colorectal cancer risk, which can be introduced, may be
of major public health importance. Two possible prescribable modifiers are
aspirin and non-steroidal anti-inflammatory drugs (NSAIDs). Two case-control
studies in the United States confirmed their protective effect.2,3 The role of
these modifiers in the Asian population is unknown.
This report describes the result of a hospital-based case-control study
conducted in three Hospital Authority hospitals from April 1998 to March 2000.
Methods
Among the 1120 and 970 subjects identified for the case and control groups, 822
cases and 926 controls, respectively, were successfully recruited and interviewed.
Using a validated questionnaire, subjects provided the following information:
(1) past medical history including the nature of the disease and age at diagnosis;
(2) a detailed family history of colorectal neoplasia and other malignancy in
first- and second-degree relatives including the nature of neoplasia and age at
diagnosis; (3) analgesia intake in the past 10 years including the type, frequency
and the amount used. Multivariate analysis was performed for significant factors
identified on univariate analysis with adjustment for possible confounders
including demographic features (sex, age, marital status, education level),
family history if appropriate and environmental risk factors (smoking habit,
drinking habit, physical activity level, and nutrient intake).
Results
Familial predisposition
Using clinical criteria alone, eight (0.9%) cases were confirmed to be suffering
from hereditary colorectal cancer syndrome. This rate was much lower than the
previously reported rate of 5% to 10%, probably due to a difference in diagnostic
criteria used (clinical vs genetic) and the method of case ascertainment (case
series vs registry data).
Key Messages
1. Individuals with a family history
of colorectal cancer as well
as individuals with medical
illnesses including diabetes,
stroke, haemorrhoids, chronic
constipation, and colorectal
polyp should be informed of
their increased risk of colorectal
cancer due to a combination of
genetic and lifestyle factors.
2. To maximise cost-effectiveness
in cancer prevention, the indi-
viduals stated above should be
targeted for preventive health
measures that include lifestyle
modifications and regular
screening programmes.
3. Further study into the possible
protective effect of aspirin and
non-steroidal anti-inflammatory
drugs in the local population
should be undertaken.
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Colorectal cancer risk: chronic illnesses, medication and family history
A family history of colorectal cancer (in either first- or
second-degree relatives) was reported by 60 (7.3%) cases
and 24 (2.6%) controls. Forty-six (5.6%) cases and 20
(2.2%) controls had at least one first-degree relative
suffering from colorectal cancer (Table 1). A family history
of colorectal cancer was significantly associated with
increased colon and rectal cancer risk. The same findings
were obtained for a history of colorectal cancer in a first-
degree relative, particularly if the first-degree relative was
a parent. Since many known personal and environmental
confounders were adjusted for in our analysis, the results
indicated that genetic predisposition is a likely cause for
the increased risk observed.
A family history of colorectal polyp in a first-degree
relative was associated with rectal cancer risk (ORadjusted=
14.32; 95% CI, 1.53-133.70) [Table 1].
A history of other cancers in their family members
was also associated with colorectal cancer risk (ORadjusted=
3.17; 95% CI, 1.18-8.52). In subsite analysis, the associa-
tion remained the same for rectal cancer (ORadjusted=4.95;
95% CI, 1.65-4.87) [Table 1].
Comparing cases diagnosed before and after 50 years of
age, we found that family history of colorectal neoplasia
was stronger for those suffering from colorectal cancer
before 50 years of age. These younger cases had a higher
number of family members suffering from colorectal can-
cer and they themselves were more likely to be suffering
from hereditary colorectal cancer syndrome (Table 2).
Underlying medical diseases
Diabetes mellitus and stroke were associated with a
significant increase in colorectal cancer risk and subsite
analysis for colon cancer. Hypertension was associated
with increased colon cancer risk before and after
adjustment for potential confounders (ORadjusted=1.33; 95%
CI, 1.03-1.72).
Colorectal diseases including colorectal polyp,
haemorrhoids and chronic constipation were associated
with increased colorectal cancer risk. For colorectal polyp
and haemorrhoids, the association remained significant
for the subsites of colon and rectal cancer. As the mean age
at haemorrhoid diagnosis was much younger than the
mean age at colorectal cancer diagnosis (44.3±16.8 years
vs 66.8±12.0 years), it is unlikely that the high prevalence
of haemorrhoids was due to misinterpreting symptoms of
colorectal cancer as a diagnosis of haemorrhoids. The
observed association for chronic constipation became
insignificant in subsite analysis.
Analgesia intake
Controls had a significantly higher analgesia usage rate
than cases (73.5% vs 65.7%, P=0.001) [Table 3]. Ever
exposure to analgesia in the past 10 years was associated
with significantly reduced colorectal cancer risk
Table 1.  Family history and colorectal cancer risk*
All cases, n=822 Colon cancer, n=452 Rectal cancer, n=357 Controls, n=926
Family history of CRC 60 30 28 24
Adjusted OR 3.14 2.83 3.49
95% CI (1.89-5.22) (1.56-5.14) (1.91-6.37)
History of CRC in FDR 46 24 20 20
Adjusted OR 2.81 2.74 2.97
95% CI (1.60-4.93) (1.41-5.31) (1.50-5.88)
History of CRC in parent 24 12 11 28
Adjusted OR 3.73 3.91 3.84
95% CI (1.62-8.61) (1.50-10.19) (1.45-10.15)
Family history of polyp 6 2 4 21
Adjusted OR 7.33 4.46 14.32
95% CI (0.87-61.52) (0.39-50.91) (1.53-133.70)
Family history of other cancer 14 5 9 26
Adjusted OR 3.17 1.99 4.95
95% CI (1.18-8.52) (0.57-6.98) (1.65-4.87)
* CRC denotes colorectal cancer, and FDR first-degree relative
Table 2.  Family history according to age at cancer diagnosis for cases*
Age (<50 yrs) Age (≥50 yrs) P value OR (95% CI)
Total No. 93 729
Family history of CRC 18 242 0.000 23.93 (2.15-7.19)22
FDR with CRC 12 234 0.003 23.03 (1.51-6.08)22
Parents with CRC 11 213 0.000 27.39 (3.21-17.03)2
Family history of colorectal polyp 23 223 0.022 28.07 (1.60-40.57)2
CRC syndrome 23 222 0.000 25.07 (4.98-126.13)
Mean No. of family members with CRC 1.88 ± 2.34 1.07 ± 0.34 0.034
* CRC denotes colorectal cancer, and FDR first-degree relative
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(ORadjusted=0.75; 95% CI, 0.60-0.94) and rectal cancer
(ORadjusted=0.67; 95% CI, 0.50-0.90). Only 64 (7.9%) cases
and 98 (10.7%) controls used analgesia on a regular basis,
that is, more than 1 month in the past 10 years.
Regular use of either aspirin or NSAIDs was associated
with significantly reduced risk of colorectal cancer
(ORadjusted=0.53; 95% CI, 0.32-0.89).
Because of this relatively low regular usage rate, we
could not demonstrate any significant association between
the extent of aspirin or NSAIDs exposure with colorectal
cancer risk.
Table 3.  Analgesia intake in the past 10 years and colorectal
cancer risk
All cases Colon Rectum Controls
n=822 n=452 n=357 n=926
Ever use analgesia 534 298 227
Adjusted OR 0.75 0.8 0.67
(95% CI) (0.60-0.94) (0.61-1.05) (0.50-0.90)
Regular use of 27 15 10 51
aspirin or NSAID*
Adjusted OR 0.53 0.5 0.5
(95% CI) (0.32-0.89) (0.26-0.95) (0.24-1.03)
* NSAID denotes non-steroidal anti-inflammatory drugs
Conclusions
Family history of colorectal cancer was an important risk
factor for colon and rectal cancer in our population. Such a
family history was stronger for cases diagnosed before 50
years old. These findings suggest genetic predisposition to
be the most likely cause for the increased risk. Medical
illnesses including diabetes mellitus and stroke, colorectal
diseases such as haemorrhoids, chronic constipation and
colorectal polyp were associated with an increased risk of
colorectal cancer. Regular intake of aspirin or NSAIDs was
associated with reduced colorectal cancer risk.
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